Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma (Q35776418)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 December 2011

Language	Label	Description	Also known as
English	Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma	scientific article published on 13 December 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

cell differentiation

1 reference

based on heuristic

inferred from title

Julie Teruya-Feldstein

8

object named as

Julie Teruya-Feldstein

0 references

author name string

Sarah T Wilkinson

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Kristie A Vanpatten

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Diane R Fernandez

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Patrick Brunhoeber

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Karl E Garsha

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Betty J Glinsmann-Gibson

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Thomas M Grogan

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Lisa M Rimsza

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

0 references

publication date

13 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

119

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1459-1467

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Aggressive lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Plasma cell ontogeny defined by quantitative changes in blimp-1 expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

The three Es of cancer immunoediting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Prognostic and predictive factors in breast cancer by immunohistochemical analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Assembly, transport, and function of MHC class II molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

27 July 2018

Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

MHC II and the endocytic pathway: regulation by invariant chain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286210

25 September 2018

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic correlation of HLA-DR expression in large cell lymphoma as determined by LN3 antibody staining. An eastern cooperative oncology group (ECOG) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution patterns of dendritic cells and T cells in diffuse large B-cell lymphomas correlate with prognoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22167754

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2011-07-363820

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35776418&oldid=2127823544"